Delivery Order SPE2DB20D1004-SPE2DB24FNCSG

Award Date 9/23/24
Potential Completion Date 9/24/24
Potential Value $1.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,639.80 firm fixed-price delivery order is for the provision of 4,566,224,269 units of the drug Mucinex D ER 600-60 mg tablets. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,036.39 firm fixed-price delivery order is for the supply of Mucinex D ER 1,200-120 mg tablets. The contract has an ultimate completion date of October 25, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,515.69 firm fixed-price delivery order is for the supply of Mucinex D ER 600-60 mg tablets, which will be delivered by February 28, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, running through November 2026, that serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Mucinex D ER 600-60 mg tablets. The firm-fixed-price delivery order, valued at $1,887.60, has an ultimate completion date of September 30, 2024. The contract is not set aside for any specific business category. AmerisourceBergen, through its Corporate Office division, will supply the requested medication to support DLA's military...
This federal contract award to AmerisourceBergen Drug Corp is a $1,459.44 firm fixed-price delivery order for Mucinex ER 600 mg tablets. The contract is non-set-aside, meaning it was open to competition. The funding agency is the Defense Logistics Agency (DLA), which is a defense agency. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that serves as a critical supplier of medical and pharmaceutical products to federal agencies, including the DLA. The company holds a significant...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, covers the delivery of MUCINEX ER 600 MG TABLET 500S to the Defense Logistics Agency (DLA). The $2,553.77 firm fixed price delivery order has a completion date of July 23, 2024. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth $999,999,999 through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,153.18 firm fixed-price delivery order is for the supply of MUCINEX D ER 600-60 MG TABLET 18S. The contract has an ultimate completion date of May 17, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This federal contract award, valued at $1,078.97, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Mucinex D ER 600-60 mg tablets, a pharmaceutical product, and has a completion date of March 13, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type, and there is no set-aside designation. AmerisourceBergen Drug Corp holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,013.25 firm-fixed-price delivery order is for the supply of 4,565,860,637 units of Mucinex D ER 1,200-120 mg tablets. The contract has an ultimate completion date of September 19, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,062.14 firm fixed-price delivery order is for the supply of MUCINEX D ER 600-60 MG TABLET 18S and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a...
  • SPE2DB20D1004
    Indefinite Delivery Contract
  • SPE2DB20D1004-SPE2DB24FNCSG
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Mucinex ER 600 mg tablets. The $1,271.70 Firm Fixed Price Delivery Order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. In addition to the DLA contract, AmerisourceBergen also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000, covering similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries.

Generated 2/27/25, 1:31 PM